Literature DB >> 23288400

Anthropometric characteristics and risk of lymphoid and myeloid leukemia in the European Prospective Investigation into Cancer and Nutrition (EPIC).

Fatemeh Saberi Hosnijeh1, Isabelle Romieu, Valentina Gallo, Elio Riboli, Anne Tjønneland, Jytte Halkjær, Guy Fagherazzi, Françoise Clavel-Chapelon, Laure Dossus, Annie Lukanova, Rudolf Kaaks, Antonia Trichopoulou, Pagona Lagiou, Michael Katsoulis, Salvatore Panico, Giovanna Tagliabue, Catalina Bonet, Miren Dorronsoro, José María Huerta, Eva Ardanaz, Maria-José Sánchez, Dorthe Johansen, Signe Borgquist, Petra Peeters, H Bas Bueno-de-Mesquita, Martine M Ros, Ruth C Travis, Timothy J Key, Paolo Vineis, Roel Vermeulen.   

Abstract

PURPOSE: Overweight and obesity have been suggested as a risk factor for leukemia. Impaired immune function associated with obesity, increased insulin-like growth factor-I activity and stimulating effects of leptin suggest a possible biological link between anthropometric measures and leukemia. However, evidence from epidemiological studies has been inconsistent. We examined the potential association between prospective measurements of body size and risk of leukemia among participants of the European Prospective Investigation into Cancer and Nutrition (EPIC).
METHODS: During follow-up (mean = 11.52 years, standard deviation = 2.63), 671 leukemia (lymphoid leukemia = 50.1 %, myeloid leukemia = 43.2 %) cases were identified. Anthropometric measures including weight, height, body mass index (BMI), waist circumference (WC), hip circumference, and waist-to-hip ratio (WHR) were measured. Cox proportional hazard models were used to explore the association between anthropometric measures and risk of leukemia.
RESULTS: No associations were observed between anthropometric measures and total leukemia, and lymphoid leukemia. Risk of myeloid leukemia significantly increased for higher categories of BMI and WC among women. Analyses by subtype of myeloid leukemia showed an increased risk of acute myeloid leukemia (AML) for higher categories of WHR among women. This association seemed to be reversed for chronic myeloid leukemia. No association between anthropometric measures and myeloid leukemia were observed among men except an increased risk of AML with height.
CONCLUSION: The study showed no associations between anthropometric measures and total leukemia, and lymphoid leukemia among men and women. A possible association between BMI as general obesity and WC as abdominal obesity and increased risk of myeloid leukemia among women were observed.

Entities:  

Mesh:

Year:  2013        PMID: 23288400     DOI: 10.1007/s10552-012-0128-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  7 in total

1.  Anthropometric, medical history and lifestyle risk factors for myeloproliferative neoplasms in the Iowa Women's Health Study cohort.

Authors:  Alexis D Leal; Carrie A Thompson; Alice H Wang; Robert A Vierkant; Thomas M Habermann; Julie A Ross; Ruben A Mesa; Beth A Virnig; James R Cerhan
Journal:  Int J Cancer       Date:  2013-10-15       Impact factor: 7.396

Review 2.  Epidemiology of MPN: what do we know?

Authors:  L A Anderson; M F McMullin
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

3.  Obesity over the life course and risk of acute myeloid leukemia and myelodysplastic syndromes.

Authors:  Jenny N Poynter; Michaela Richardson; Cindy K Blair; Michelle A Roesler; Betsy A Hirsch; Phuong Nguyen; Adina Cioc; Erica Warlick; James R Cerhan; Julie A Ross
Journal:  Cancer Epidemiol       Date:  2015-12-22       Impact factor: 2.984

4.  Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis.

Authors:  Shufen Li; Li Chen; Wen Jin; Xuefei Ma; Yunlin Ma; Fangyi Dong; Hongming Zhu; Junmin Li; Kankan Wang
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

5.  Obesity is a risk factor for acute promyelocytic leukemia: evidence from population and cross-sectional studies and correlation with FLT3 mutations and polyunsaturated fatty acid metabolism.

Authors:  Luca Mazzarella; Edoardo Botteri; Anthony Matthews; Elena Gatti; Davide Di Salvatore; Vincenzo Bagnardi; Massimo Breccia; Pau Montesinos; Teresa Bernal; Cristina Gil; Timothy J Ley; Miguel Sanz; Krishnan Bhaskaran; Francesco Lo Coco; Pier Giuseppe Pelicci
Journal:  Haematologica       Date:  2019-09-12       Impact factor: 9.941

6.  Waist circumference and risk of 23 site-specific cancers: a population-based cohort study of Korean adults.

Authors:  Kyu Rae Lee; Mi Hae Seo; Kyung Do Han; Jinhyung Jung; In Cheol Hwang
Journal:  Br J Cancer       Date:  2018-10-17       Impact factor: 7.640

7.  Leptin modification in chronic myeloid leukemia patients treated with imatinib: An emerging effect of targeted therapy.

Authors:  Stefania Mariani; Sabrina Basciani; Fiorina Giona; Carla Lubrano; Salvatore Ulisse; Lucio Gnessi
Journal:  Leuk Res Rep       Date:  2013-08-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.